文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Evolving paradigms in prostate cancer screening: a decade of bibliometric insights and technological advancements.

作者信息

Chai Keqiang, Xu Changhong, Man Jiangwei, Deng Yun, Yang Li

机构信息

Department of Urology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu, China.

Department of Urology, Institute of Urology, Gansu Province Clinical Research Center for Urinary System Disease, Lanzhou University Second Hospital, Lanzhou, Gansu, China.

出版信息

Front Oncol. 2025 Feb 25;15:1511880. doi: 10.3389/fonc.2025.1511880. eCollection 2025.


DOI:10.3389/fonc.2025.1511880
PMID:40071089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11893402/
Abstract

OBJECTIVE: Prostate cancer is a major threat to global male health. This study uses bibliometric methods to analyze the dynamics and trends in prostate cancer screening research, with the aim of optimizing screening strategies and informing policy decisions. METHODS: Utilizing the Web of Science Core Collection database, this study retrieved prostate cancer screening-related literature published between 2014 and 2024, totaling 5,409 articles. Data processing and analysis were conducted using CiteSpace and the Bibliometrix R package, including citation network analysis, co-word analysis, cluster analysis, and trend analysis. RESULTS: The analysis revealed the following key findings: (1) Global literature on prostate cancer screening has grown annually, with the United States, Europe, and China leading research activity; (2) Research hotspots include the risks and benefits of prostate-specific antigen (PSA) testing, MRI-based screening technologies, and the use of molecular and genetic biomarkers; (3) Emerging technologies, such as machine learning and nanodiagnostic techniques, are enhancing diagnostic precision and reducing overdiagnosis; (4) Network analysis of collaborations reveals a shift toward transnational and interdisciplinary research, particularly in integrating biomedical and computer science to drive rapid advancements in screening technologies. CONCLUSION: This study confirms the ongoing vibrancy and technological advancement in the global field of prostate cancer screening research, emphasizing the trend towards precision medicine. Future development of prostate cancer screening strategies should focus on risk-adapted screening and the application of novel biomarkers to optimize screening outcomes and reduce unnecessary medical interventions.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/e09c5ad27e1f/fonc-15-1511880-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/8c999de6863e/fonc-15-1511880-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/e2d98acaeb67/fonc-15-1511880-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/b7ba5ad70b92/fonc-15-1511880-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/c8a765a92672/fonc-15-1511880-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/c582e385cc77/fonc-15-1511880-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/c0d8c01ea641/fonc-15-1511880-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/e09c5ad27e1f/fonc-15-1511880-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/8c999de6863e/fonc-15-1511880-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/e2d98acaeb67/fonc-15-1511880-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/b7ba5ad70b92/fonc-15-1511880-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/c8a765a92672/fonc-15-1511880-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/c582e385cc77/fonc-15-1511880-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/c0d8c01ea641/fonc-15-1511880-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/11893402/e09c5ad27e1f/fonc-15-1511880-g007.jpg

相似文献

[1]
Evolving paradigms in prostate cancer screening: a decade of bibliometric insights and technological advancements.

Front Oncol. 2025-2-25

[2]
Research hotspots and frontiers of machine learning in renal medicine: a bibliometric and visual analysis from 2013 to 2024.

Int Urol Nephrol. 2025-3

[3]
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.

Front Biosci (Landmark Ed). 2022-8-31

[4]
Bibliometric analysis of laryngeal cancer treatment literature (2003-2023).

Heliyon. 2024-12-16

[5]
Exploring research trends and hotspots on oxidative stress and bronchopulmonary dysplasia: Insights from bibliometric and visualized study.

Pediatr Pulmonol. 2024-12

[6]
Global research trends and focus on immunotherapy for endometrial cancer: a comprehensive bibliometric insight and visualization analysis (2012-2024).

Front Immunol. 2025-4-8

[7]
Radiomics in precision medicine for colorectal cancer: a bibliometric analysis (2013-2023).

Front Oncol. 2024-10-30

[8]
Trends and prospects in nursing care for diabetic foot: A bibliometric analysis from 2003 to 2023.

J Tissue Viability. 2024-11

[9]
Trends and hotspots in gastrointestinal neoplasms risk assessment: A bibliometric analysis from 1984 to 2022.

World J Gastrointest Oncol. 2024-6-15

[10]
Bibliometric analysis of the Top 1000 most-cited articles in otolaryngology over the past decade: global research trends and hotspots.

Front Surg. 2025-2-17

本文引用的文献

[1]
Dual-Enhanced SERS Satellite Immuno-Nanocomplex for Multiple PSA-Mediated PHI Assay Toward Clinical Prostate Cancer Screening.

Adv Sci (Weinh). 2025-2

[2]
Photoacoustic imaging in prostate cancer: A new paradigm for diagnosis and management.

Photodiagnosis Photodyn Ther. 2024-6

[3]
Prostate-specific Membrane Antigen: Diagnostics.

PET Clin. 2024-7

[4]
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

Eur Urol. 2024-8

[5]
Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING).

Eur Urol Focus. 2024-3

[6]
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw. 2023-10

[7]
Screening for Prostate Cancer.

N Engl J Med. 2023-7-6

[8]
Genetically adjusted PSA levels for prostate cancer screening.

Nat Med. 2023-6

[9]
Metastatic prostate cancer management: 20 years of progress.

Lancet Oncol. 2023-5

[10]
Screening for Prostate Cancer.

N Engl J Med. 2023-4-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索